 Monika Fleshner
Concepts (699)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 59 | 2017 | 1145 | 6.990 |
Why?
| | Stress, Physiological | 47 | 2019 | 443 | 6.850 |
Why?
| | Prebiotics | 8 | 2025 | 28 | 4.580 |
Why?
| | Physical Conditioning, Animal | 22 | 2019 | 242 | 4.060 |
Why?
| | Rats, Inbred F344 | 48 | 2019 | 268 | 3.230 |
Why?
| | Rats | 137 | 2024 | 5582 | 3.230 |
Why?
| | Motor Activity | 28 | 2019 | 718 | 3.110 |
Why?
| | HSP72 Heat-Shock Proteins | 17 | 2014 | 31 | 2.980 |
Why?
| | Helplessness, Learned | 13 | 2016 | 67 | 2.790 |
Why?
| | Corticosterone | 38 | 2016 | 241 | 2.120 |
Why?
| | Running | 14 | 2016 | 230 | 2.040 |
Why?
| | Brain | 27 | 2024 | 2934 | 1.870 |
Why?
| | Rats, Sprague-Dawley | 71 | 2024 | 2524 | 1.820 |
Why?
| | Glucans | 2 | 2025 | 22 | 1.720 |
Why?
| | Oligosaccharides | 2 | 2025 | 60 | 1.690 |
Why?
| | Heat-Shock Proteins | 10 | 2024 | 139 | 1.670 |
Why?
| | Animals | 164 | 2025 | 37952 | 1.660 |
Why?
| | Gastrointestinal Microbiome | 5 | 2025 | 766 | 1.480 |
Why?
| | Cytokines | 17 | 2024 | 2048 | 1.410 |
Why?
| | Electroshock | 28 | 2015 | 145 | 1.380 |
Why?
| | Immune System | 9 | 2017 | 177 | 1.380 |
Why?
| | Fear | 17 | 2015 | 367 | 1.350 |
Why?
| | Escherichia coli Infections | 9 | 2012 | 125 | 1.300 |
Why?
| | Exosomes | 5 | 2017 | 104 | 1.300 |
Why?
| | Circadian Rhythm | 7 | 2021 | 512 | 1.240 |
Why?
| | Hemocyanins | 19 | 2008 | 61 | 1.210 |
Why?
| | Interleukin-1beta | 6 | 2016 | 390 | 1.200 |
Why?
| | Bacteria | 7 | 2024 | 765 | 1.190 |
Why?
| | Inflammation | 12 | 2024 | 2876 | 1.110 |
Why?
| | Inflammasomes | 3 | 2016 | 144 | 1.100 |
Why?
| | Immunity, Innate | 9 | 2014 | 834 | 1.080 |
Why?
| | Proto-Oncogene Proteins c-fos | 11 | 2019 | 196 | 1.080 |
Why?
| | Physical Exertion | 6 | 2012 | 205 | 1.070 |
Why?
| | Exercise | 17 | 2024 | 2191 | 1.060 |
Why?
| | Corpus Striatum | 7 | 2017 | 179 | 1.060 |
Why?
| | Gastrointestinal Tract | 3 | 2016 | 204 | 1.050 |
Why?
| | Lactoferrin | 2 | 2018 | 36 | 1.030 |
Why?
| | Spleen | 13 | 2013 | 507 | 1.030 |
Why?
| | Anxiety | 10 | 2018 | 1117 | 1.020 |
Why?
| | Immunoglobulin M | 11 | 2008 | 265 | 0.980 |
Why?
| | Feces | 4 | 2025 | 494 | 0.960 |
Why?
| | Serotonin | 10 | 2019 | 296 | 0.950 |
Why?
| | Male | 145 | 2024 | 72664 | 0.940 |
Why?
| | Diet | 5 | 2024 | 1277 | 0.940 |
Why?
| | Neuronal Plasticity | 12 | 2018 | 305 | 0.920 |
Why?
| | Interleukin-1 | 15 | 2008 | 961 | 0.910 |
Why?
| | Hypergravity | 1 | 2025 | 6 | 0.910 |
Why?
| | Antibody Formation | 10 | 2008 | 287 | 0.890 |
Why?
| | Amygdala | 7 | 2017 | 199 | 0.870 |
Why?
| | MicroRNAs | 3 | 2017 | 686 | 0.860 |
Why?
| | Sympathetic Nervous System | 4 | 2014 | 181 | 0.850 |
Why?
| | Receptors, Adrenergic, alpha-1 | 7 | 2014 | 45 | 0.820 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 163 | 0.810 |
Why?
| | Lipopolysaccharides | 11 | 2024 | 858 | 0.800 |
Why?
| | Raphe Nuclei | 7 | 2019 | 111 | 0.770 |
Why?
| | Behavior, Animal | 13 | 2019 | 519 | 0.760 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2025 | 507 | 0.740 |
Why?
| | Hippocampus | 18 | 2017 | 969 | 0.730 |
Why?
| | Conditioning, Classical | 7 | 2015 | 119 | 0.700 |
Why?
| | Adipose Tissue | 3 | 2016 | 644 | 0.700 |
Why?
| | Glycolipids | 2 | 2019 | 53 | 0.660 |
Why?
| | Neuroendocrine Cells | 1 | 2020 | 33 | 0.650 |
Why?
| | Catecholamines | 7 | 2014 | 88 | 0.650 |
Why?
| | Stress Disorders, Post-Traumatic | 8 | 2021 | 890 | 0.640 |
Why?
| | Immunoglobulin G | 13 | 2008 | 887 | 0.640 |
Why?
| | Conditioning, Operant | 5 | 2012 | 94 | 0.630 |
Why?
| | Microbiota | 2 | 2019 | 729 | 0.630 |
Why?
| | Dopamine | 3 | 2015 | 294 | 0.620 |
Why?
| | Receptor, Serotonin, 5-HT2C | 4 | 2012 | 14 | 0.610 |
Why?
| | Gene Expression Regulation | 8 | 2014 | 2588 | 0.610 |
Why?
| | Glycoproteins | 2 | 2019 | 354 | 0.590 |
Why?
| | Tumor Necrosis Factor-alpha | 7 | 2016 | 1216 | 0.590 |
Why?
| | Body Weight | 15 | 2016 | 969 | 0.570 |
Why?
| | Mentors | 1 | 2021 | 216 | 0.560 |
Why?
| | Interleukin-10 | 7 | 2016 | 309 | 0.560 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2018 | 153 | 0.560 |
Why?
| | Prefrontal Cortex | 5 | 2017 | 333 | 0.550 |
Why?
| | Microglia | 2 | 2021 | 270 | 0.550 |
Why?
| | Sleep | 4 | 2021 | 887 | 0.520 |
Why?
| | Alarmins | 1 | 2017 | 27 | 0.520 |
Why?
| | Fatigue | 3 | 2012 | 363 | 0.510 |
Why?
| | Signal Transduction | 10 | 2023 | 5208 | 0.500 |
Why?
| | Inflammation Mediators | 4 | 2013 | 506 | 0.500 |
Why?
| | Escape Reaction | 6 | 2012 | 55 | 0.500 |
Why?
| | Food Deprivation | 1 | 2016 | 28 | 0.500 |
Why?
| | Vagus Nerve | 7 | 2000 | 92 | 0.500 |
Why?
| | Analysis of Variance | 15 | 2015 | 1300 | 0.480 |
Why?
| | Sleep, REM | 1 | 2016 | 44 | 0.470 |
Why?
| | Receptors, Glucocorticoid | 4 | 2013 | 129 | 0.460 |
Why?
| | Butyrates | 1 | 2016 | 66 | 0.460 |
Why?
| | Emotions | 3 | 2018 | 573 | 0.460 |
Why?
| | Central Nervous System | 2 | 2016 | 281 | 0.460 |
Why?
| | Association Learning | 3 | 2010 | 70 | 0.450 |
Why?
| | RNA, Messenger | 12 | 2018 | 2803 | 0.450 |
Why?
| | Neuroimmunomodulation | 8 | 2003 | 67 | 0.450 |
Why?
| | Mood Disorders | 1 | 2016 | 139 | 0.440 |
Why?
| | Macrophages, Peritoneal | 2 | 2014 | 89 | 0.440 |
Why?
| | Norepinephrine | 6 | 2006 | 200 | 0.440 |
Why?
| | Interleukin-6 | 7 | 2016 | 775 | 0.430 |
Why?
| | Chemokines | 2 | 2012 | 217 | 0.430 |
Why?
| | Interleukin-18 | 2 | 2012 | 234 | 0.420 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1993 | 0.420 |
Why?
| | Serum | 1 | 2014 | 58 | 0.420 |
Why?
| | Extracellular Space | 3 | 2005 | 117 | 0.420 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2016 | 189 | 0.410 |
Why?
| | Receptors, Adrenergic | 1 | 2013 | 20 | 0.410 |
Why?
| | Time Factors | 25 | 2016 | 7107 | 0.400 |
Why?
| | Arousal | 9 | 2021 | 157 | 0.400 |
Why?
| | Sleep Deprivation | 4 | 2020 | 206 | 0.400 |
Why?
| | Adaptation, Physiological | 6 | 2007 | 560 | 0.400 |
Why?
| | Adipose Tissue, White | 1 | 2013 | 42 | 0.400 |
Why?
| | Receptor, Serotonin, 5-HT1A | 3 | 2016 | 36 | 0.390 |
Why?
| | Reward | 3 | 2016 | 248 | 0.390 |
Why?
| | Chemokine CCL2 | 4 | 2014 | 112 | 0.380 |
Why?
| | Glucocorticoids | 5 | 2012 | 531 | 0.380 |
Why?
| | Psychoneuroimmunology | 3 | 2005 | 9 | 0.380 |
Why?
| | Transcortin | 6 | 2007 | 14 | 0.370 |
Why?
| | Intestines | 1 | 2015 | 354 | 0.370 |
Why?
| | Immune Tolerance | 3 | 2005 | 385 | 0.360 |
Why?
| | Injections, Intraperitoneal | 11 | 2008 | 115 | 0.360 |
Why?
| | Respiratory Tract Infections | 2 | 2016 | 394 | 0.360 |
Why?
| | Antigens | 4 | 2003 | 348 | 0.360 |
Why?
| | Obesity, Abdominal | 1 | 2012 | 47 | 0.360 |
Why?
| | Nitric Oxide | 6 | 2014 | 892 | 0.350 |
Why?
| | Aminopyridines | 3 | 2009 | 129 | 0.350 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 339 | 0.340 |
Why?
| | Myeloid Cells | 1 | 2012 | 146 | 0.340 |
Why?
| | Mifepristone | 3 | 2001 | 53 | 0.320 |
Why?
| | Body Temperature | 5 | 2014 | 227 | 0.320 |
Why?
| | Mental Health | 2 | 2015 | 791 | 0.320 |
Why?
| | Freezing Reaction, Cataleptic | 4 | 2012 | 27 | 0.320 |
Why?
| | Limbic System | 1 | 2010 | 55 | 0.320 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 8 | 2014 | 847 | 0.320 |
Why?
| | Neurons | 8 | 2017 | 1644 | 0.310 |
Why?
| | Memory | 9 | 2015 | 294 | 0.310 |
Why?
| | Metagenome | 1 | 2010 | 126 | 0.310 |
Why?
| | Volition | 1 | 2009 | 34 | 0.300 |
Why?
| | Space Flight | 2 | 2000 | 70 | 0.300 |
Why?
| | Random Allocation | 3 | 2016 | 365 | 0.300 |
Why?
| | Extracellular Fluid | 3 | 2006 | 38 | 0.300 |
Why?
| | Brain Chemistry | 3 | 2005 | 117 | 0.300 |
Why?
| | Disease Models, Animal | 13 | 2016 | 4552 | 0.300 |
Why?
| | Depression | 3 | 2012 | 1537 | 0.300 |
Why?
| | Locomotion | 2 | 2012 | 101 | 0.290 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 10 | 0.290 |
Why?
| | Lipid Droplets | 2 | 2019 | 21 | 0.290 |
Why?
| | Electric Stimulation | 9 | 2013 | 276 | 0.290 |
Why?
| | Up-Regulation | 4 | 2012 | 846 | 0.290 |
Why?
| | Predatory Behavior | 5 | 2011 | 52 | 0.280 |
Why?
| | Exercise Therapy | 3 | 2008 | 475 | 0.280 |
Why?
| | Indoles | 3 | 2009 | 507 | 0.280 |
Why?
| | Exercise Test | 3 | 2007 | 626 | 0.280 |
Why?
| | Fluvoxamine | 1 | 2008 | 17 | 0.280 |
Why?
| | Antibodies | 3 | 2005 | 397 | 0.270 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2008 | 58 | 0.270 |
Why?
| | Mycobacterium | 2 | 2021 | 101 | 0.270 |
Why?
| | B-Lymphocytes | 2 | 2003 | 866 | 0.270 |
Why?
| | Homeostasis | 3 | 2017 | 639 | 0.260 |
Why?
| | Heat-Shock Response | 2 | 2024 | 77 | 0.260 |
Why?
| | Adrenal Glands | 8 | 2008 | 76 | 0.260 |
Why?
| | Adrenalectomy | 11 | 2005 | 68 | 0.260 |
Why?
| | Pituitary-Adrenal System | 4 | 2012 | 164 | 0.250 |
Why?
| | Humans | 46 | 2024 | 145140 | 0.250 |
Why?
| | Extinction, Psychological | 3 | 2015 | 92 | 0.250 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2012 | 199 | 0.250 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.250 |
Why?
| | Physical Fitness | 2 | 2006 | 207 | 0.240 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 93 | 0.240 |
Why?
| | Heart Rate | 6 | 2016 | 855 | 0.240 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2005 | 19 | 0.230 |
Why?
| | Adjuvants, Immunologic | 4 | 2003 | 243 | 0.230 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2024 | 129 | 0.230 |
Why?
| | Galactose | 1 | 2025 | 34 | 0.230 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 499 | 0.230 |
Why?
| | Neural Pathways | 4 | 2015 | 312 | 0.230 |
Why?
| | Vagotomy | 8 | 2000 | 33 | 0.230 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 6 | 0.220 |
Why?
| | In Situ Hybridization | 4 | 2012 | 318 | 0.220 |
Why?
| | Cognition | 6 | 2024 | 1262 | 0.220 |
Why?
| | Immunomodulation | 2 | 2017 | 99 | 0.220 |
Why?
| | Physical Endurance | 1 | 2006 | 276 | 0.220 |
Why?
| | Adrenocorticotropic Hormone | 7 | 2013 | 147 | 0.220 |
Why?
| | Sick Role | 1 | 2004 | 20 | 0.210 |
Why?
| | Dose-Response Relationship, Drug | 10 | 2013 | 2026 | 0.210 |
Why?
| | Immunization | 6 | 2021 | 375 | 0.210 |
Why?
| | Psychomotor Performance | 3 | 2019 | 324 | 0.210 |
Why?
| | Persian Gulf Syndrome | 1 | 2024 | 18 | 0.210 |
Why?
| | Physiology | 1 | 2024 | 13 | 0.210 |
Why?
| | Memory Disorders | 3 | 2013 | 197 | 0.210 |
Why?
| | Long-Term Potentiation | 7 | 1999 | 199 | 0.200 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 153 | 0.200 |
Why?
| | Encephalitis | 1 | 2005 | 142 | 0.200 |
Why?
| | Morphine | 5 | 2011 | 168 | 0.200 |
Why?
| | Social Behavior | 4 | 2016 | 284 | 0.200 |
Why?
| | CD5 Antigens | 1 | 2003 | 10 | 0.190 |
Why?
| | CD11 Antigens | 1 | 2003 | 30 | 0.190 |
Why?
| | Propranolol | 3 | 2008 | 44 | 0.190 |
Why?
| | Genes, fos | 1 | 2003 | 36 | 0.190 |
Why?
| | Hypothalamus | 4 | 2017 | 163 | 0.190 |
Why?
| | Muscle Strength | 1 | 2006 | 332 | 0.190 |
Why?
| | Lung | 1 | 2016 | 4101 | 0.190 |
Why?
| | Myocardium | 4 | 2007 | 931 | 0.180 |
Why?
| | Protein Biosynthesis | 1 | 2005 | 451 | 0.180 |
Why?
| | Microdialysis | 4 | 2015 | 56 | 0.180 |
Why?
| | Depressive Disorder | 3 | 2012 | 372 | 0.180 |
Why?
| | B-Lymphocyte Subsets | 1 | 2002 | 76 | 0.180 |
Why?
| | Medicine | 1 | 2024 | 125 | 0.180 |
Why?
| | Lymph Nodes | 5 | 2006 | 502 | 0.180 |
Why?
| | Dehydroepiandrosterone | 3 | 1997 | 49 | 0.170 |
Why?
| | Maze Learning | 6 | 2015 | 105 | 0.170 |
Why?
| | T-Lymphocyte Subsets | 2 | 1995 | 417 | 0.170 |
Why?
| | Cross-Over Studies | 1 | 2024 | 608 | 0.170 |
Why?
| | Dehydroepiandrosterone Sulfate | 3 | 1999 | 43 | 0.170 |
Why?
| | Bacteroidetes | 1 | 2021 | 21 | 0.170 |
Why?
| | Interferon-gamma | 4 | 2001 | 784 | 0.170 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2000 | 1138 | 0.170 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 252 | 0.170 |
Why?
| | Gene Expression | 2 | 2018 | 1474 | 0.170 |
Why?
| | Sex Characteristics | 2 | 2006 | 775 | 0.170 |
Why?
| | Tyrosine 3-Monooxygenase | 3 | 2016 | 72 | 0.170 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 589 | 0.170 |
Why?
| | Weightlessness Simulation | 1 | 2000 | 6 | 0.170 |
Why?
| | Pituitary Gland | 5 | 2006 | 149 | 0.160 |
Why?
| | Weightlessness | 1 | 2000 | 40 | 0.160 |
Why?
| | Acoustic Stimulation | 7 | 2015 | 333 | 0.160 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2013 | 31 | 0.160 |
Why?
| | Neurosecretory Systems | 1 | 2000 | 31 | 0.160 |
Why?
| | Radiation Effects | 1 | 1999 | 7 | 0.160 |
Why?
| | Avoidance Learning | 2 | 2013 | 63 | 0.150 |
Why?
| | Astronauts | 1 | 1999 | 29 | 0.150 |
Why?
| | Exploratory Behavior | 3 | 2015 | 85 | 0.150 |
Why?
| | Dentate Gyrus | 2 | 2010 | 41 | 0.150 |
Why?
| | Mental Recall | 4 | 1997 | 217 | 0.150 |
Why?
| | Blood Proteins | 2 | 2002 | 238 | 0.150 |
Why?
| | Fever | 3 | 2011 | 318 | 0.150 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5972 | 0.150 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 29 | 0.150 |
Why?
| | Tryptophan Hydroxylase | 1 | 2019 | 54 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 450 | 0.150 |
Why?
| | Citrate (si)-Synthase | 4 | 2007 | 57 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 4 | 2024 | 483 | 0.150 |
Why?
| | Prazosin | 2 | 2011 | 25 | 0.140 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 52 | 0.140 |
Why?
| | RNA, Bacterial | 1 | 2020 | 182 | 0.140 |
Why?
| | Serotonin 5-HT2 Receptor Agonists | 2 | 2008 | 7 | 0.140 |
Why?
| | Mice | 8 | 2025 | 18303 | 0.140 |
Why?
| | Cells, Cultured | 5 | 2014 | 4142 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 571 | 0.130 |
Why?
| | Cats | 5 | 2015 | 228 | 0.130 |
Why?
| | Dexamethasone | 3 | 2001 | 365 | 0.130 |
Why?
| | Toll-Like Receptors | 2 | 2011 | 193 | 0.130 |
Why?
| | Biomedical Research | 1 | 2024 | 717 | 0.130 |
Why?
| | Lymphocytes | 4 | 2011 | 376 | 0.130 |
Why?
| | Peptides | 2 | 2013 | 997 | 0.120 |
Why?
| | Exercise Movement Techniques | 1 | 2016 | 6 | 0.120 |
Why?
| | Analgesics, Opioid | 3 | 2012 | 1145 | 0.120 |
Why?
| | Female | 22 | 2025 | 78636 | 0.120 |
Why?
| | Behavior | 2 | 2006 | 89 | 0.120 |
Why?
| | Leukocyte Count | 3 | 2002 | 316 | 0.120 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 837 | 0.120 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2016 | 154 | 0.120 |
Why?
| | Immunoglobulins | 1 | 1996 | 161 | 0.120 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 70 | 0.120 |
Why?
| | Bacterial Vaccines | 1 | 2016 | 63 | 0.120 |
Why?
| | Dysgammaglobulinemia | 1 | 1995 | 2 | 0.110 |
Why?
| | IgG Deficiency | 1 | 1995 | 6 | 0.110 |
Why?
| | Aging | 3 | 2004 | 1962 | 0.110 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2016 | 147 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 248 | 0.110 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 87 | 0.110 |
Why?
| | Immunity | 3 | 2002 | 140 | 0.110 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1995 | 49 | 0.110 |
Why?
| | Host-Pathogen Interactions | 2 | 2015 | 361 | 0.110 |
Why?
| | Symbiosis | 1 | 2015 | 72 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 195 | 0.110 |
Why?
| | CD4 Antigens | 1 | 1995 | 137 | 0.110 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1789 | 0.110 |
Why?
| | Tyrosine | 2 | 2005 | 217 | 0.110 |
Why?
| | Neuralgia | 1 | 2016 | 140 | 0.110 |
Why?
| | Dynorphins | 1 | 2014 | 8 | 0.110 |
Why?
| | Hydrocortisone | 3 | 2015 | 298 | 0.110 |
Why?
| | Enkephalins | 1 | 2014 | 21 | 0.110 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 11 | 0.110 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 23 | 0.100 |
Why?
| | Nitrites | 3 | 2016 | 87 | 0.100 |
Why?
| | Culture Media | 1 | 2014 | 161 | 0.100 |
Why?
| | Peritoneum | 3 | 2003 | 43 | 0.100 |
Why?
| | Receptors, Dopamine D1 | 1 | 2014 | 34 | 0.100 |
Why?
| | Metabolomics | 1 | 2020 | 730 | 0.100 |
Why?
| | Tail | 4 | 1998 | 28 | 0.100 |
Why?
| | Primary Cell Culture | 1 | 2014 | 172 | 0.100 |
Why?
| | Convulsants | 1 | 1993 | 8 | 0.100 |
Why?
| | Anxiety Disorders | 2 | 2008 | 368 | 0.100 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 2005 | 34 | 0.100 |
Why?
| | Carbolines | 1 | 1993 | 35 | 0.100 |
Why?
| | Acute-Phase Reaction | 2 | 2007 | 37 | 0.100 |
Why?
| | Immunity, Cellular | 3 | 2005 | 273 | 0.100 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 46 | 0.100 |
Why?
| | Hyperalgesia | 3 | 2016 | 127 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 968 | 0.100 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2013 | 75 | 0.100 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 454 | 0.100 |
Why?
| | History, 21st Century | 2 | 2024 | 220 | 0.100 |
Why?
| | Bradykinin | 1 | 2013 | 49 | 0.100 |
Why?
| | Molecular Probes | 1 | 2013 | 33 | 0.100 |
Why?
| | Colitis | 1 | 2016 | 280 | 0.100 |
Why?
| | Amnesia | 2 | 2011 | 47 | 0.100 |
Why?
| | Telemetry | 1 | 2013 | 40 | 0.090 |
Why?
| | History, 20th Century | 2 | 2024 | 327 | 0.090 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2012 | 11 | 0.090 |
Why?
| | Cues | 3 | 2015 | 327 | 0.090 |
Why?
| | Diaphragm | 3 | 1998 | 48 | 0.090 |
Why?
| | Reaction Time | 3 | 2012 | 431 | 0.090 |
Why?
| | Synaptotagmin I | 1 | 2012 | 15 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1325 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2012 | 1163 | 0.090 |
Why?
| | Thymus Gland | 3 | 2008 | 311 | 0.090 |
Why?
| | Phenylephrine | 2 | 2001 | 74 | 0.090 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 81 | 0.090 |
Why?
| | Fetal Blood | 1 | 2014 | 325 | 0.090 |
Why?
| | Body Fat Distribution | 1 | 2012 | 46 | 0.090 |
Why?
| | Lipid Bilayers | 1 | 2013 | 103 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 329 | 0.090 |
Why?
| | Life Style | 2 | 2005 | 483 | 0.090 |
Why?
| | Rats, Nude | 1 | 2012 | 25 | 0.090 |
Why?
| | Injections, Subcutaneous | 2 | 2003 | 170 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 946 | 0.090 |
Why?
| | Pulmonary Fibrosis | 1 | 2016 | 395 | 0.090 |
Why?
| | Gliosarcoma | 1 | 1992 | 8 | 0.090 |
Why?
| | Caspase 1 | 1 | 2012 | 146 | 0.090 |
Why?
| | Thiazepines | 2 | 2013 | 6 | 0.090 |
Why?
| | Lymphocyte Transfusion | 1 | 1992 | 20 | 0.090 |
Why?
| | Veterans | 1 | 2024 | 1625 | 0.090 |
Why?
| | Lymphocyte Count | 2 | 2003 | 163 | 0.090 |
Why?
| | Cell Communication | 1 | 2014 | 328 | 0.090 |
Why?
| | Saimiri | 1 | 2011 | 11 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1154 | 0.090 |
Why?
| | Neurobiology | 1 | 2011 | 14 | 0.090 |
Why?
| | Macrophages | 2 | 2000 | 1500 | 0.090 |
Why?
| | Uric Acid | 1 | 2012 | 167 | 0.090 |
Why?
| | Locus Coeruleus | 1 | 2011 | 25 | 0.080 |
Why?
| | Cell Survival | 1 | 2014 | 1100 | 0.080 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 49 | 0.080 |
Why?
| | Body Composition | 1 | 2015 | 690 | 0.080 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 10 | 0.080 |
Why?
| | Laparotomy | 1 | 2011 | 113 | 0.080 |
Why?
| | Endocrine Glands | 1 | 1990 | 14 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2012 | 140 | 0.080 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 273 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 337 | 0.080 |
Why?
| | C-Reactive Protein | 3 | 2024 | 422 | 0.080 |
Why?
| | Aged | 5 | 2008 | 26096 | 0.080 |
Why?
| | Interleukin-2 | 1 | 1992 | 440 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 505 | 0.080 |
Why?
| | Rats, Inbred Strains | 6 | 1995 | 321 | 0.080 |
Why?
| | Epinephrine | 3 | 2004 | 158 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 275 | 0.080 |
Why?
| | Microinjections | 2 | 2008 | 92 | 0.080 |
Why?
| | Liver | 4 | 2006 | 1893 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1713 | 0.080 |
Why?
| | Pain | 4 | 2011 | 781 | 0.080 |
Why?
| | Cell Count | 2 | 2002 | 319 | 0.080 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 25 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 456 | 0.080 |
Why?
| | CA1 Region, Hippocampal | 1 | 2009 | 49 | 0.070 |
Why?
| | Glucose | 1 | 2014 | 1048 | 0.070 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2001 | 65 | 0.070 |
Why?
| | Reference Values | 5 | 2007 | 798 | 0.070 |
Why?
| | Neutrophils | 3 | 2011 | 1123 | 0.070 |
Why?
| | Naltrexone | 4 | 1994 | 115 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 517 | 0.070 |
Why?
| | Nadolol | 1 | 2008 | 3 | 0.070 |
Why?
| | Analgesics | 1 | 1990 | 230 | 0.070 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 57 | 0.070 |
Why?
| | Insulin | 2 | 2016 | 2510 | 0.070 |
Why?
| | Escherichia coli | 2 | 2002 | 834 | 0.070 |
Why?
| | Immunotherapy, Adoptive | 1 | 1992 | 342 | 0.070 |
Why?
| | Flow Cytometry | 2 | 2003 | 1159 | 0.070 |
Why?
| | Isoproterenol | 1 | 2008 | 96 | 0.070 |
Why?
| | Adrenergic beta-Agonists | 1 | 2008 | 92 | 0.070 |
Why?
| | Pyrazines | 1 | 2008 | 92 | 0.070 |
Why?
| | Injections, Intraventricular | 4 | 1998 | 59 | 0.070 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 25 | 0.070 |
Why?
| | Substantia Nigra | 1 | 2008 | 63 | 0.070 |
Why?
| | Aggression | 1 | 1989 | 178 | 0.070 |
Why?
| | Lipids | 1 | 2012 | 706 | 0.070 |
Why?
| | Nerve Net | 1 | 2010 | 284 | 0.060 |
Why?
| | Weight Loss | 1 | 1993 | 845 | 0.060 |
Why?
| | Mesentery | 2 | 1998 | 44 | 0.060 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 17 | 0.060 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2006 | 46 | 0.060 |
Why?
| | Recombinant Proteins | 5 | 2000 | 1368 | 0.060 |
Why?
| | Computational Biology | 1 | 2011 | 669 | 0.060 |
Why?
| | Blood Glucose | 1 | 2016 | 2335 | 0.060 |
Why?
| | Fluoxetine | 1 | 2006 | 56 | 0.060 |
Why?
| | Estrous Cycle | 1 | 2006 | 22 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2007 | 181 | 0.060 |
Why?
| | Piperazines | 1 | 2008 | 375 | 0.060 |
Why?
| | Pulmonary Edema | 1 | 2006 | 105 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 715 | 0.060 |
Why?
| | Labetalol | 1 | 2005 | 6 | 0.060 |
Why?
| | Mianserin | 1 | 2005 | 3 | 0.060 |
Why?
| | Methyltyrosines | 1 | 2005 | 3 | 0.060 |
Why?
| | Hypophysectomy | 1 | 2005 | 12 | 0.060 |
Why?
| | Immunoglobulin alpha-Chains | 1 | 2005 | 1 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2767 | 0.060 |
Why?
| | Hypertrophy | 2 | 2007 | 128 | 0.060 |
Why?
| | Phosphorylation | 3 | 2017 | 1706 | 0.060 |
Why?
| | Exocytosis | 1 | 2005 | 85 | 0.050 |
Why?
| | RNA | 1 | 2011 | 910 | 0.050 |
Why?
| | Spectrophotometry | 1 | 2005 | 58 | 0.050 |
Why?
| | Evoked Potentials | 3 | 1996 | 131 | 0.050 |
Why?
| | Postural Balance | 1 | 2008 | 244 | 0.050 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2002 | 58 | 0.050 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 62 | 0.050 |
Why?
| | Progesterone | 1 | 2006 | 214 | 0.050 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1955 | 0.050 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 30 | 0.050 |
Why?
| | Down-Regulation | 1 | 2006 | 618 | 0.050 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2004 | 55 | 0.050 |
Why?
| | Antibody Specificity | 1 | 2004 | 177 | 0.050 |
Why?
| | Physical Education and Training | 1 | 2024 | 70 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 2000 | 1131 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2005 | 201 | 0.050 |
Why?
| | Concanavalin A | 1 | 2003 | 72 | 0.050 |
Why?
| | Hypertension | 1 | 2013 | 1269 | 0.050 |
Why?
| | Blood Pressure | 4 | 2015 | 1778 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 234 | 0.050 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2003 | 19 | 0.050 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 8 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2006 | 385 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2005 | 260 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2004 | 160 | 0.050 |
Why?
| | Estrogens | 1 | 2006 | 367 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 34 | 0.050 |
Why?
| | Leukocytes | 1 | 2005 | 296 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2005 | 372 | 0.050 |
Why?
| | Adult | 10 | 2024 | 40665 | 0.050 |
Why?
| | Biology | 1 | 2024 | 88 | 0.050 |
Why?
| | Nucleus Accumbens | 2 | 2016 | 134 | 0.050 |
Why?
| | Analgesia | 2 | 1994 | 105 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2005 | 360 | 0.050 |
Why?
| | Colony-Forming Units Assay | 1 | 2002 | 95 | 0.050 |
Why?
| | Dermatitis | 1 | 2002 | 20 | 0.050 |
Why?
| | Biomarkers | 3 | 2015 | 4282 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 520 | 0.050 |
Why?
| | Forecasting | 1 | 2004 | 388 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 386 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 1992 | 1328 | 0.040 |
Why?
| | Hot Temperature | 2 | 2021 | 396 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2003 | 335 | 0.040 |
Why?
| | Cell Membrane | 1 | 2005 | 707 | 0.040 |
Why?
| | Naloxone | 3 | 2012 | 131 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 2024 | 199 | 0.040 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 7 | 0.040 |
Why?
| | Cell Division | 1 | 2003 | 753 | 0.040 |
Why?
| | Immunologic Memory | 1 | 2004 | 368 | 0.040 |
Why?
| | Acute Disease | 2 | 2002 | 1035 | 0.040 |
Why?
| | Reflex, Startle | 2 | 2015 | 75 | 0.040 |
Why?
| | Universities | 1 | 2024 | 443 | 0.040 |
Why?
| | Epitopes | 1 | 2003 | 473 | 0.040 |
Why?
| | Risk Factors | 1 | 2016 | 10857 | 0.040 |
Why?
| | Injections, Intravenous | 2 | 1998 | 197 | 0.040 |
Why?
| | Immunoglobulin Isotypes | 1 | 2001 | 36 | 0.040 |
Why?
| | Hormone Antagonists | 1 | 2001 | 32 | 0.040 |
Why?
| | Middle Aged | 4 | 2024 | 36126 | 0.040 |
Why?
| | Mycobacteriaceae | 1 | 2021 | 34 | 0.040 |
Why?
| | Learning | 3 | 2008 | 443 | 0.040 |
Why?
| | Macrophage-1 Antigen | 1 | 2000 | 26 | 0.040 |
Why?
| | Neurons, Afferent | 2 | 1998 | 102 | 0.040 |
Why?
| | Spironolactone | 1 | 2001 | 40 | 0.040 |
Why?
| | Health Status | 1 | 2006 | 832 | 0.040 |
Why?
| | Skin | 2 | 2002 | 753 | 0.040 |
Why?
| | Complement Activation | 1 | 2003 | 399 | 0.040 |
Why?
| | Hypogravity | 1 | 1999 | 5 | 0.040 |
Why?
| | Receptors, Mineralocorticoid | 1 | 1999 | 11 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3138 | 0.040 |
Why?
| | Radiation Injuries, Experimental | 1 | 1999 | 20 | 0.040 |
Why?
| | Cells | 1 | 1999 | 25 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1999 | 140 | 0.040 |
Why?
| | Radiometry | 1 | 1999 | 56 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 396 | 0.040 |
Why?
| | Chronic Disease | 1 | 2006 | 1806 | 0.040 |
Why?
| | Electrophysiology | 2 | 1999 | 218 | 0.040 |
Why?
| | Obesity | 1 | 1993 | 3097 | 0.040 |
Why?
| | Restraint, Physical | 3 | 2010 | 75 | 0.040 |
Why?
| | Social Isolation | 1 | 1999 | 73 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 740 | 0.040 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1999 | 100 | 0.040 |
Why?
| | alpha-MSH | 1 | 1998 | 6 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 217 | 0.040 |
Why?
| | Eating | 3 | 2000 | 387 | 0.040 |
Why?
| | Erythrocytes | 1 | 2005 | 747 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 331 | 0.040 |
Why?
| | Peritoneal Cavity | 1 | 1998 | 30 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2127 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 3 | 2007 | 253 | 0.030 |
Why?
| | Staphylococcal Infections | 2 | 2000 | 390 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 1999 | 105 | 0.030 |
Why?
| | Administration, Oral | 1 | 2001 | 862 | 0.030 |
Why?
| | United States | 1 | 2016 | 16065 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 198 | 0.030 |
Why?
| | Polysomnography | 1 | 2019 | 239 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2881 | 0.030 |
Why?
| | Individuality | 1 | 2019 | 149 | 0.030 |
Why?
| | Bacteriophages | 1 | 1999 | 110 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1763 | 0.030 |
Why?
| | Wakefulness | 1 | 2019 | 170 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 280 | 0.030 |
Why?
| | Electroencephalography | 1 | 2021 | 561 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2016 | 17247 | 0.030 |
Why?
| | Oxytocics | 1 | 1997 | 15 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1597 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1999 | 337 | 0.030 |
Why?
| | Antigens, CD | 1 | 2000 | 558 | 0.030 |
Why?
| | Altitude | 1 | 2001 | 462 | 0.030 |
Why?
| | Monitoring, Physiologic | 2 | 2008 | 288 | 0.030 |
Why?
| | Dinoprostone | 1 | 1997 | 180 | 0.030 |
Why?
| | Receptors, Purinergic P2X5 | 1 | 2016 | 3 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2016 | 4 | 0.030 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2016 | 14 | 0.030 |
Why?
| | p21-Activated Kinases | 1 | 2016 | 13 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1177 | 0.030 |
Why?
| | Weight Gain | 1 | 2000 | 561 | 0.030 |
Why?
| | Sciatic Neuropathy | 1 | 2016 | 30 | 0.030 |
Why?
| | Orientation | 1 | 1996 | 50 | 0.030 |
Why?
| | Anesthesia | 2 | 1990 | 256 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 88 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 211 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3918 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 1996 | 61 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 1998 | 291 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1999 | 355 | 0.030 |
Why?
| | Azides | 1 | 1996 | 49 | 0.030 |
Why?
| | Neuroglia | 1 | 2017 | 173 | 0.030 |
Why?
| | Attention | 1 | 2019 | 461 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2016 | 135 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 248 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 240 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 264 | 0.030 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 68 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 146 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 166 | 0.030 |
Why?
| | Stem Cells | 1 | 1999 | 624 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 221 | 0.030 |
Why?
| | Immobilization | 1 | 2015 | 53 | 0.030 |
Why?
| | Spinal Cord | 2 | 2004 | 382 | 0.030 |
Why?
| | Cytological Techniques | 1 | 1995 | 27 | 0.030 |
Why?
| | Drug Synergism | 2 | 2011 | 354 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1261 | 0.030 |
Why?
| | Nylons | 1 | 1995 | 24 | 0.030 |
Why?
| | Neck | 1 | 1995 | 108 | 0.030 |
Why?
| | Macrophage Activation | 1 | 1996 | 181 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 469 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4538 | 0.030 |
Why?
| | Cholesterol | 1 | 1996 | 406 | 0.030 |
Why?
| | Melatonin | 1 | 2015 | 163 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 573 | 0.020 |
Why?
| | Memory, Short-Term | 2 | 2008 | 267 | 0.020 |
Why?
| | Phosphatidylserines | 1 | 2013 | 62 | 0.020 |
Why?
| | Static Electricity | 1 | 2013 | 114 | 0.020 |
Why?
| | Clonidine | 1 | 2013 | 33 | 0.020 |
Why?
| | CD4-CD8 Ratio | 1 | 1992 | 23 | 0.020 |
Why?
| | Amitriptyline | 1 | 2013 | 24 | 0.020 |
Why?
| | Neural Inhibition | 1 | 1994 | 178 | 0.020 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 6 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 407 | 0.020 |
Why?
| | Fasting | 1 | 2014 | 276 | 0.020 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 8 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 157 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 6055 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 165 | 0.020 |
Why?
| | Drug Administration Routes | 1 | 2012 | 42 | 0.020 |
Why?
| | Anthropometry | 1 | 1993 | 205 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 151 | 0.020 |
Why?
| | Pain Threshold | 1 | 2012 | 72 | 0.020 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2012 | 3 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 85 | 0.020 |
Why?
| | Adolescent Health Services | 1 | 1993 | 74 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2012 | 68 | 0.020 |
Why?
| | Self Administration | 1 | 2012 | 122 | 0.020 |
Why?
| | Hand Strength | 2 | 2004 | 144 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 204 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 171 | 0.020 |
Why?
| | Sex Factors | 2 | 2008 | 2099 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 118 | 0.020 |
Why?
| | Sialoglycoproteins | 2 | 2004 | 157 | 0.020 |
Why?
| | Linear Models | 2 | 2004 | 844 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 1992 | 246 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1992 | 177 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 333 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 1990 | 44 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 11741 | 0.020 |
Why?
| | Pentobarbital | 1 | 1990 | 17 | 0.020 |
Why?
| | Urethane | 1 | 1990 | 43 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 259 | 0.020 |
Why?
| | Vasopressins | 1 | 1990 | 61 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2012 | 202 | 0.020 |
Why?
| | Adolescent | 3 | 2004 | 22479 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1992 | 886 | 0.020 |
Why?
| | Behavior Therapy | 1 | 1993 | 294 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2010 | 165 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 9 | 0.020 |
Why?
| | Immunity, Mucosal | 1 | 2011 | 98 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 27 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 31 | 0.020 |
Why?
| | Risk Assessment | 1 | 1999 | 3740 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2008 | 8318 | 0.020 |
Why?
| | Noise | 1 | 2010 | 72 | 0.020 |
Why?
| | Drinking | 2 | 1999 | 44 | 0.020 |
Why?
| | Bites and Stings | 1 | 1989 | 30 | 0.020 |
Why?
| | Program Evaluation | 1 | 1993 | 943 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 196 | 0.020 |
Why?
| | Posture | 1 | 1989 | 197 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 459 | 0.020 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2007 | 5 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 146 | 0.020 |
Why?
| | E-Selectin | 1 | 2007 | 61 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2185 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 891 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 198 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 132 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2006 | 69 | 0.010 |
Why?
| | Epithelial Sodium Channels | 1 | 2006 | 21 | 0.010 |
Why?
| | Cell Line | 1 | 1992 | 2821 | 0.010 |
Why?
| | Action Potentials | 3 | 1999 | 502 | 0.010 |
Why?
| | Protein Binding | 1 | 2012 | 2235 | 0.010 |
Why?
| | Sodium Channels | 1 | 2006 | 63 | 0.010 |
Why?
| | Nanoparticles | 1 | 2012 | 516 | 0.010 |
Why?
| | Models, Animal | 1 | 2007 | 393 | 0.010 |
Why?
| | Epithelium | 1 | 2006 | 310 | 0.010 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 19 | 0.010 |
Why?
| | Receptors, HIV | 1 | 2004 | 22 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 25 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 36 | 0.010 |
Why?
| | Autoimmunity | 1 | 1991 | 932 | 0.010 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2004 | 30 | 0.010 |
Why?
| | Bronchi | 1 | 2006 | 263 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1048 | 0.010 |
Why?
| | Injections, Spinal | 1 | 2004 | 119 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 99 | 0.010 |
Why?
| | Drug Implants | 2 | 1996 | 83 | 0.010 |
Why?
| | Complement C4a | 1 | 2003 | 9 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 135 | 0.010 |
Why?
| | Social Environment | 2 | 1996 | 252 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 183 | 0.010 |
Why?
| | Histamine | 1 | 2003 | 52 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2003 | 168 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2004 | 762 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2004 | 194 | 0.010 |
Why?
| | Isometric Contraction | 1 | 2004 | 190 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 315 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 28 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2001 | 25 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 419 | 0.010 |
Why?
| | Mental Status Schedule | 1 | 2001 | 35 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2004 | 429 | 0.010 |
Why?
| | Cholecystokinin | 1 | 2000 | 15 | 0.010 |
Why?
| | Mathematics | 1 | 2001 | 101 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2000 | 80 | 0.010 |
Why?
| | Menstrual Cycle | 1 | 2001 | 145 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 2000 | 182 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 409 | 0.010 |
Why?
| | Dimerization | 1 | 2000 | 189 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 386 | 0.010 |
Why?
| | Listeriosis | 1 | 2000 | 63 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 161 | 0.010 |
Why?
| | Ovary | 1 | 2001 | 231 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2006 | 933 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 2000 | 68 | 0.010 |
Why?
| | Cerebellum | 1 | 2000 | 224 | 0.010 |
Why?
| | Glossopharyngeal Nerve | 1 | 1998 | 11 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 718 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5411 | 0.010 |
Why?
| | Afferent Pathways | 1 | 1998 | 46 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 1998 | 128 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 14176 | 0.010 |
Why?
| | Nodose Ganglion | 1 | 1997 | 5 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 2000 | 471 | 0.010 |
Why?
| | Amnesia, Retrograde | 1 | 1996 | 6 | 0.010 |
Why?
| | Appetitive Behavior | 1 | 1996 | 6 | 0.010 |
Why?
| | Sodium Azide | 1 | 1996 | 5 | 0.010 |
Why?
| | Synaptic Membranes | 1 | 1996 | 16 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1996 | 48 | 0.010 |
Why?
| | Zymosan | 1 | 1996 | 39 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3616 | 0.010 |
Why?
| | Space Perception | 1 | 1996 | 82 | 0.010 |
Why?
| | Neoplasms | 1 | 2011 | 2900 | 0.010 |
Why?
| | Chlorisondamine | 1 | 1994 | 3 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 10 | 0.010 |
Why?
| | Skin Temperature | 1 | 1993 | 36 | 0.010 |
Why?
| | Binding Sites | 1 | 1996 | 1309 | 0.010 |
Why?
| | Child | 1 | 1993 | 22670 | 0.010 |
Why?
| | Pyramidal Tracts | 1 | 1992 | 30 | 0.010 |
Why?
| | Cold Temperature | 1 | 1993 | 206 | 0.010 |
Why?
| | Regression Analysis | 1 | 1992 | 998 | 0.000 |
Why?
| | Mitochondria | 1 | 1996 | 992 | 0.000 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1988 | 2 | 0.000 |
Why?
|
|
Fleshner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|